Table 4.
Association of ART and OS markers in the HIV/PTB co-infected patients
| Parameter | HIV/PTB (ART treated)β | HIV/PTB (ART naïve)β | P-value |
| Vitamin C (mg/dl) Median(IQR) | 0.14(0.10–0.17) | 0.28(0.12–0.41) | 0.03 |
| Albumin (g/l) Median(IQR) | 39.5(27.9–48.90) | 25.5(21.80–31.30) | 0.001 |
| TP (mg/ml) Median(IQR) | 44.0(37.65–45.35) | 41.8(37.10–44.80) | 0.39 |
| TAS (mmol/l) Median(IQR) | 1.2(1.06–1.87) | 1.7(1.12–2.37) | 0.06 |
| MDA(µM) Median(IQR) | 1.3(1.51–1.85) | 1.7(1.59–1.91) | 0.65 |
| ALT(IU) Median(IQR) | 9.9(5.9–17.05) | 7.0(4.7–12.70) | 0.24 |
| AST(IU) Median(IQR) | 39.2(24.45–57.30) | 54.2(22.70–72.20) | 0.29 |
| GGT(IU) Median(IQR) | 77.5(45.0–180.0) | 70.0(46.50–172) | 0.95 |
Abbreviations: ART=Antiretroviral therapy, TP=Total protein, TAS=Total antioxidant status MDA=Malondialdehyde, ALT=Alanine transaminase, AST=Aspartate transaminase, GGT=Gamma glutamyl transpeptidase.
Legend:
β
All patients were HIV/TB co-infected